ID   ZN397_HUMAN             Reviewed;         534 AA.
AC   Q8NF99; Q9BRM2;
DT   28-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   31-OCT-2003, sequence version 2.
DT   28-JUN-2023, entry version 180.
DE   RecName: Full=Zinc finger protein 397;
DE   AltName: Full=Zinc finger and SCAN domain-containing protein 15;
DE   AltName: Full=Zinc finger protein 47;
GN   Name=ZNF397; Synonyms=ZNF47, ZSCAN15;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), FUNCTION, SUBUNIT,
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Hepatoma;
RX   PubMed=12801647; DOI=10.1016/s0378-1119(03)00551-1;
RA   Wu Y., Yu L., Bi G., Luo K., Zhou G., Zhao S.;
RT   "Identification and characterization of two novel human SCAN domain-
RT   containing zinc finger genes ZNF396 and ZNF397.";
RL   Gene 310:193-201(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [4]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-171, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-55; LYS-171; LYS-202 AND LYS-251,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Isoform 3 acts as a DNA-dependent transcriptional repressor.
CC       {ECO:0000269|PubMed:12801647}.
CC   -!- SUBUNIT: Isoforms 1 and 3 can both homo- and hetero-associate. Homo-
CC       association of isoform 1 is dependent on the presence of the SCAN
CC       domain. {ECO:0000269|PubMed:12801647}.
CC   -!- INTERACTION:
CC       Q8NF99; P61968: LMO4; NbExp=3; IntAct=EBI-10213894, EBI-2798728;
CC       Q8NF99; P54646: PRKAA2; NbExp=3; IntAct=EBI-10213894, EBI-1383852;
CC       Q8NF99; Q86VK4: ZNF410; NbExp=3; IntAct=EBI-10213894, EBI-720304;
CC       Q8NF99; Q9NWS9: ZNF446; NbExp=4; IntAct=EBI-10213894, EBI-3925851;
CC       Q8NF99; Q9NWS9-2: ZNF446; NbExp=5; IntAct=EBI-10213894, EBI-740232;
CC       Q8NF99-2; P57086: SCAND1; NbExp=4; IntAct=EBI-11524467, EBI-745846;
CC       Q8NF99-2; A0A0S2Z6X0: ZKSCAN4; NbExp=4; IntAct=EBI-11524467, EBI-16431094;
CC       Q8NF99-2; Q969J2: ZKSCAN4; NbExp=3; IntAct=EBI-11524467, EBI-2818641;
CC       Q8NF99-2; Q9NWS9-2: ZNF446; NbExp=5; IntAct=EBI-11524467, EBI-740232;
CC       Q8NF99-2; O43309: ZSCAN12; NbExp=3; IntAct=EBI-11524467, EBI-1210440;
CC       Q8NF99-2; P10073: ZSCAN22; NbExp=3; IntAct=EBI-11524467, EBI-10178224;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Nucleus. Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=ZNF397-fu;
CC         IsoId=Q8NF99-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NF99-2; Sequence=VSP_006924, VSP_006925;
CC       Name=3; Synonyms=Truncated, ZNF397-nf;
CC         IsoId=Q8NF99-3; Sequence=VSP_042491, VSP_042492;
CC   -!- TISSUE SPECIFICITY: Expressed strongly in testis, moderately in
CC       skeletal muscle, pancreas and prostate, and weakly in heart, placenta,
CC       liver, kidney, spleen, thymus and small intestine.
CC       {ECO:0000269|PubMed:12801647}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION: [Isoform 3]:
CC       Sequence=AAN65175.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF533250; AAM95991.2; -; mRNA.
DR   EMBL; AY157641; AAN65175.1; ALT_FRAME; mRNA.
DR   EMBL; BC006172; AAH06172.1; -; mRNA.
DR   CCDS; CCDS32814.1; -. [Q8NF99-2]
DR   CCDS; CCDS45852.1; -. [Q8NF99-1]
DR   RefSeq; NP_001128650.1; NM_001135178.2. [Q8NF99-1]
DR   RefSeq; NP_115723.1; NM_032347.2. [Q8NF99-2]
DR   RefSeq; XP_011524533.1; XM_011526231.2. [Q8NF99-1]
DR   RefSeq; XP_016881531.1; XM_017026042.1.
DR   AlphaFoldDB; Q8NF99; -.
DR   SMR; Q8NF99; -.
DR   BioGRID; 124033; 63.
DR   IntAct; Q8NF99; 37.
DR   STRING; 9606.ENSP00000331577; -.
DR   iPTMnet; Q8NF99; -.
DR   PhosphoSitePlus; Q8NF99; -.
DR   BioMuta; ZNF397; -.
DR   DMDM; 38258943; -.
DR   EPD; Q8NF99; -.
DR   jPOST; Q8NF99; -.
DR   MassIVE; Q8NF99; -.
DR   MaxQB; Q8NF99; -.
DR   PaxDb; Q8NF99; -.
DR   PeptideAtlas; Q8NF99; -.
DR   ProteomicsDB; 73277; -. [Q8NF99-1]
DR   ProteomicsDB; 73278; -. [Q8NF99-2]
DR   ProteomicsDB; 73279; -. [Q8NF99-3]
DR   Antibodypedia; 8557; 234 antibodies from 28 providers.
DR   DNASU; 84307; -.
DR   Ensembl; ENST00000261333.10; ENSP00000261333.5; ENSG00000186812.13. [Q8NF99-2]
DR   Ensembl; ENST00000330501.12; ENSP00000331577.6; ENSG00000186812.13. [Q8NF99-1]
DR   Ensembl; ENST00000585800.1; ENSP00000466760.1; ENSG00000186812.13. [Q8NF99-3]
DR   Ensembl; ENST00000591206.5; ENSP00000466317.1; ENSG00000186812.13. [Q8NF99-3]
DR   GeneID; 84307; -.
DR   KEGG; hsa:84307; -.
DR   MANE-Select; ENST00000330501.12; ENSP00000331577.6; NM_001135178.3; NP_001128650.1.
DR   UCSC; uc002kyi.4; human. [Q8NF99-1]
DR   AGR; HGNC:18818; -.
DR   CTD; 84307; -.
DR   GeneCards; ZNF397; -.
DR   HGNC; HGNC:18818; ZNF397.
DR   HPA; ENSG00000186812; Low tissue specificity.
DR   MIM; 609601; gene.
DR   neXtProt; NX_Q8NF99; -.
DR   OpenTargets; ENSG00000186812; -.
DR   PharmGKB; PA38694; -.
DR   VEuPathDB; HostDB:ENSG00000186812; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000162078; -.
DR   HOGENOM; CLU_002678_49_3_1; -.
DR   InParanoid; Q8NF99; -.
DR   OMA; DCENSES; -.
DR   OrthoDB; 4330481at2759; -.
DR   PhylomeDB; Q8NF99; -.
DR   TreeFam; TF338304; -.
DR   PathwayCommons; Q8NF99; -.
DR   SignaLink; Q8NF99; -.
DR   BioGRID-ORCS; 84307; 10 hits in 1180 CRISPR screens.
DR   ChiTaRS; ZNF397; human.
DR   GenomeRNAi; 84307; -.
DR   Pharos; Q8NF99; Tbio.
DR   PRO; PR:Q8NF99; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; Q8NF99; protein.
DR   Bgee; ENSG00000186812; Expressed in secondary oocyte and 181 other tissues.
DR   ExpressionAtlas; Q8NF99; baseline and differential.
DR   Genevisible; Q8NF99; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd07936; SCAN; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 9.
DR   Gene3D; 1.10.4020.10; DNA breaking-rejoining enzymes; 1.
DR   InterPro; IPR003309; SCAN_dom.
DR   InterPro; IPR038269; SCAN_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR23226; ZINC FINGER AND SCAN DOMAIN-CONTAINING; 1.
DR   PANTHER; PTHR23226:SF76; ZINC FINGER AND SCAN DOMAIN-CONTAINING PROTEIN 23; 1.
DR   Pfam; PF02023; SCAN; 1.
DR   Pfam; PF00096; zf-C2H2; 9.
DR   SMART; SM00431; SCAN; 1.
DR   SMART; SM00355; ZnF_C2H2; 9.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 5.
DR   SUPFAM; SSF47353; Retrovirus capsid dimerization domain-like; 1.
DR   PROSITE; PS50804; SCAN_BOX; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 9.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 9.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..534
FT                   /note="Zinc finger protein 397"
FT                   /id="PRO_0000047564"
FT   DOMAIN          50..132
FT                   /note="SCAN box"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00187"
FT   ZN_FING         285..307
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         313..335
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         341..363
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         369..391
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         397..419
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         425..447
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         453..475
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         481..503
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         509..531
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          180..217
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   CROSSLNK        55
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        171
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:25755297,
FT                   ECO:0007744|PubMed:28112733"
FT   CROSSLNK        202
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        251
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         186..207
FT                   /note="DCENSETATKEGISEEKSQGLP -> GEEWEIIWKLLTLRPLFLRMQN (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12801647"
FT                   /id="VSP_042491"
FT   VAR_SEQ         208..534
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12801647"
FT                   /id="VSP_042492"
FT   VAR_SEQ         216..275
FT                   /note="SEHESNLVWKQGSATGEKLRSPSQGGSFSQVIFTNKSLGKRDLYDEAERCLI
FT                   LTTDSIMC -> KLSRPPKASSAIRWECVSPGSFPGDIIAAEATHSTISCFAINTLPAT
FT                   ILPSKNVNRKYFS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_006924"
FT   VAR_SEQ         276..534
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_006925"
SQ   SEQUENCE   534 AA;  61139 MW;  E990609DABABDE2A CRC64;
     MAVESGVIST LIPQDPPEQE LILVKVEDNF SWDEKFKQNG STQSCQELFR QQFRKFCYQE
     TPGPREALSR LQELCYQWLM PELHTKEQIL ELLVLEQFLS ILPEELQIWV QQHNPESGEE
     AVTLLEDLER EFDDPGQQVP ASPQGPAVPW KDLTCLRASQ ESTDIHLQPL KTQLKSWKPC
     LSPKSDCENS ETATKEGISE EKSQGLPQEP SFRGISEHES NLVWKQGSAT GEKLRSPSQG
     GSFSQVIFTN KSLGKRDLYD EAERCLILTT DSIMCQKVPP EERPYRCDVC GHSFKQHSSL
     TQHQRIHTGE KPYKCNQCGK AFSLRSYLII HQRIHSGEKA YECSECGKAF NQSSALIRHR
     KIHTGEKACK CNECGKAFSQ SSYLIIHQRI HTGEKPYECN ECGKTFSQSS KLIRHQRIHT
     GERPYECNEC GKAFRQSSEL ITHQRIHSGE KPYECSECGK AFSLSSNLIR HQRIHSGEEP
     YQCNECGKTF KRSSALVQHQ RIHSGDEAYI CNECGKAFRH RSVLMRHQRV HTIK
//
